The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...

A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said. The treatment, called VIR-5500, harnesses the body’s ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

(MENAFN- EIN Presswire) EINPresswire/ -- The Prostate Cancer Drugs Market was valued at US$ 13.22 billion in 2024 and is projected to reach US$ 28.10 billion by 2033, growing at a CAGR of 8.1 percent ...

No increased risk for thrombosis or bleeding seen with concurrent use of enzalutamide, apalutamide, or abiraterone with DOACs ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants published by Wiley online in CANCER, investigators found ...

Drug Used for Enlarged Prostate Tied to High Glaucoma Risk The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study ...

The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...

Dear Dr. Donohue • Last May, I had a prostate biopsy. I was told that it didn't show cancer but that there were precancerous cells. My urologist recommended that I take finasteride (Proscar). However, ...

A prostate cancer study that could change how doctors treat some patients found that widely used hormone-blocking drugs did not improve survival chances for older men whose disease hadn't spread. In ...